Human Genome Epidemiology Literature Finder
|
Records 1 - 3 (of 3 Records) |
| Query Trace: Neoplasms and RIPK3[original query] |
|---|
| BRAF and AXL oncogenes drive RIPK3 expression loss in cancer. PLoS biology 2018 8 16 (8): e2005756. Najafov Ayaz, Zervantonakis Ioannis K, Mookhtiar Adnan K, Greninger Patricia, March Ryan J, Egan Regina K, Luu Hoang Son, Stover Daniel G, Matulonis Ursula A, Benes Cyril H, Yuan Junyi |
| The association of germline variants with chronic lymphocytic leukemia outcome suggests the implication of novel genes and pathways in clinical evolution. BMC cancer 2019 May 19 (1): 515. Mosquera Orgueira Adrián, Antelo Rodríguez Beatriz, Alonso Vence Natalia, Díaz Arias José Ángel, Díaz Varela Nicolás, Pérez Encinas Manuel Mateo, Allegue Toscano Catarina, Goiricelaya Seco Elena María, Carracedo Álvarez Ángel, Bello López José Lu |
| RIPK3 is a novel prognostic marker for lower grade glioma and further enriches IDH mutational status subgrouping. Journal of neuro-oncology 2020 3 147 (3): 587-594. Vergara Guilherme Afonso, Eugenio Gisele Cristine, Malheiros Suzana Maria Fleury, Victor Elivane da Silva, Weinlich Ricar |
- Page last reviewed:Feb 1, 2024
- Content source:

